TMDX - TransMedics Group, Inc

Healthcare - Sector

TMDX is currently covered by 6 analysts with average potential upside of $9.85 (37.9%) backed by 17 price targets and 54 ratings. Analyst's average stock valuation to be materialised ratio is 84.87% with an average time for price targets to be met of 149 days.

Most recent stock forecast was given by CECILIA FURLONG from MORGAN STANLEY on 04-Nov-2022.

Highest price target for TMDX is 56, Lowest price target is 16, average price target is 36.

Best performing analysts who are covering TMDX - TransMedics Group, Inc:

William Plovanic Suraj Kalia Joshua Jennings Allen Gong David Lewis Cecilia Furlong

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

54

$-5.25 (-8.86%)

45

23 days ago

11/13 (84.62%)

$2.48 (12.24%)

100

Buy

45

$-14.25 (-24.05%)

49

3 months 25 days ago

5/6 (83.33%)

$10.83 (44.38%)

173

Buy

58

$-1.25 (-2.11%)

46

3 months 25 days ago

5/9 (55.56%)

$28.99 (102.54%)

132

Hold

48

$-11.25 (-18.99%)

20

3 months 25 days ago

4/4 (100%)

$3.32 (10.29%)

23

Buy

45

$-14.25 (-24.05%)

39

4 months 1 days ago

11/11 (100%)

$10.91 (45.52%)

270

Show more analysts

This chart will make you best informed on how analysts see your stock and which of them does well in less than two minutes.

28 days free trial

We do our best to collect, sort, and check every available news item on your stocks so that you can focus on what is important

For each analyst know for every call if it has been before or after the stock price moved

Understand how each analyst reacts to stock price movement

Get Started or Login